Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human FGF-8a Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 4745F8050
This item is not returnable.
View return policy
Description
The Recombinant Human FGF-8a Protein is derived from E. coli. The Recombinant Human FGF-8a Protein has been validated for the following applications: Bioactivity.Specifications
Lyophilized from a 0.2 μm filtered solution in MOPS, Na 2 SO 4 and EDTA. | |
21 kDa | |
50μg | |
12 months from date of receipt, ≤ -20° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, ≤ -20° C under sterile conditions after reconstitution. | |
Recombinant |
2253 | |
FGF-8 a Isoform | |
E. coli-derived human FGF-8 protein Gln23-Arg204,with an N-terminal Met | |
Unconjugated | |
95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction